Todder Doron, Levartovsky Meital, Dwolatzky Tzvi
Beer Sheva Mental Health Center, Ministry of Health, Israel.
Faculty of Health, Ben Gurion University, Beer Sheva, Israel.
Harefuah. 2016 Dec;155(12):727-730.
The most common cause of dementia is Alzheimer's disease. The major manifestation of the disease is the cognitive impairment which appears at the onset of the disease. In addition to the cognitive impairment there are behavioral dysfunctions such as apathy, anxiety, depression and sleep disturbances. The treatment for the manifestations of Alzheimer is currently pharmacological and behavioral. One of the newest behavioral treatments for Alzheimer is the multi-sensory treatment using the Snoezelen room.
The study group included 16 hospitalized Alzheimer patients. A device called the ActiGraph, which reads movement level, was placed on the subjects' non-dominant wrist. The measurements took place continually for five nights: two nights before snoezelen treatment, the day of treatment and two nights after the treatment. This protocol was repeated after a week of rest.
The results showed that snoezelen treatment has a positive effect on the quality of sleep during the first week but not on the second week.
Snoezelen treatment should be considered as part of the treatment regimen of Alzheimer patients, in addition to the pharmacological treatments in order to improve their quality of sleep and quality of life. Larger sample size and longer periods of time are needed to confirm the effectiveness of the treatment.
痴呆最常见的病因是阿尔茨海默病。该病的主要表现是疾病发作时出现的认知障碍。除认知障碍外，还存在行为功能障碍，如冷漠、焦虑、抑郁和睡眠障碍。目前针对阿尔茨海默病表现的治疗方法是药物治疗和行为治疗。阿尔茨海默病最新的行为治疗方法之一是使用斯鲁泽林室进行多感官治疗。
研究组包括16名住院的阿尔茨海默病患者。在受试者的非优势手腕上放置一个名为活动记录仪的设备，用于读取活动水平。测量持续进行五个晚上：斯鲁泽林治疗前两晚、治疗当天以及治疗后两晚。休息一周后重复该方案。
结果表明，斯鲁泽林治疗在第一周对睡眠质量有积极影响，但在第二周没有。
除药物治疗外，斯鲁泽林治疗应被视为阿尔茨海默病患者治疗方案的一部分，以改善他们的睡眠质量和生活质量。需要更大的样本量和更长的时间来证实该治疗的有效性。
